Pharmaceutical Business Development

Halo BioConsulting is a pharmaceutical business development consulting firm providing a broad portfolio of commercial and transactional advisory services to pharmaceutical and biotechnology companies and investors in the life sciences sector.

Halo BioConsulting's services include:

- In-licensing opportunities - identification, evaluation & deal-closure

- Out-licensing partners - identification, evaluation & deal-closure

- Commercial management & business planning

- M&A/alliance identification & evaluation

- Commercial review & development of start-up companies

- Investor & investee identification

- Non-Exec Director, SAB and C-level interim management roles

- Due diligence (scientific, clinical, & commercial)

- Supporting European commercial activities of US pharma companies

- General advisory services to life science investors

Founder of Halo BioConsulting, Dr Kieran Rooney, is a senior pharma/biotech professional with a successful 25 year career in drug discovery R&D, clinical drug development, business development and commercial management in the pharma/biotech sector. He has a proven track record in building and commercializing life science companies, including successfully developing and delivering commercial strategies through to company exit. In addition to Board-level experience in a variety of life science companies, he has closed multiple multinational licensing and investment deals. He has broad commercial, technology and therapeutic experience across multiple franchises and business models in pharma/biotech.

Kieran earned his doctorate in neuropharmacology from the University of Wales, and was a postdoctoral research fellow at the Universities of Nottingham & Bristol. He has a degree in pharmacy and is a member of the Royal Pharmaceutical Society of Great Britain.

Contact:

Dr Kieran Rooney

Tel: +44 (0) 7733 260060

E-mail: consulting@halobio.com

Address: Halo BioConsulting Ltd, P.O. Box 291, Ilkley, LS29 1ED, UK